Voss E M, Sharkey S W, Gernert A E, Murakami M M, Johnston R B, Hsieh C C, Apple F S
Department of Laboratory Medicine and Pathology, Clinical Chemistry, Hennepin County Medical Center, Minneapolis, Minn. 55415, USA.
Arch Pathol Lab Med. 1995 Sep;119(9):799-806.
Cardiac troponin T (cTnT) has been suggested as a new, more specific marker of myocardial cellular damage. The objectives of this study were to examine the distribution of cTnT and creatine kinase (CK)-MB in normal and diseased heart tissue of dogs and humans, and to assess the use of serum cTnT for the estimation of infarct size in dogs.
Serial serum specimens over 7 days were obtained from normal dogs (controls, n = 3) and dogs that underwent surgical coronary artery occlusion (n = 6). Heart muscle samples were obtained from the controls and after 3 weeks of occlusion in experimental dogs. Diseased human heart muscle samples were obtained at autopsy from patients who had died of acute myocardial infarction (n = 3). Normal heart muscle samples (n = 3) were obtained at autopsy from patients who died of non-cardiac-related illnesses. Tissues were sectioned and homogenized to harvest both cytosolic and myofibril-bound proteins. Serum samples and tissue homogenates were assayed for cTnT, CK-MB, and myoglobin (humans only). Total protein was assayed on homogenate samples and results were reported as milligrams per gram of total protein.
The distributions of cTnT, CK-MB, and myoglobin were equivalent across 14 sites within normal human heart. Creatine kinase-MB and myoglobin were more than 99% cytosolic. Cardiac troponin T was 92% myofibril bound and 8% cytosolic. In the control dog hearts, cTnT was higher and CK-MB was lower in the right ventricle than in the left ventricle. While CK-MB and myoglobin were more than 99% cytosolic, cTnT was 98% myofibril bound and 2% cytosolic. Infarct sizing in dog hearts initially did not correlate well with serum cTnT or CK-MB concentrations. However, when the data were separated by infarct location (right coronary artery; left circumflex coronary artery), the correlations improved dramatically. Differences in tissue concentrations of cTnT and CK-MB between the left and right ventricle might explain the change in correlations. Coronary artery occlusion in dogs and humans resulted in decreased cytosolic and myofibril cTnT and increased CK-MB and myoglobin in diseased myocardial tissue.
Our observed biochemical alterations suggest that the energy-producing proteins CK-MB and myoglobin are upregulated following cellular damage, while the structural and regulatory protein cTnT does not have a mechanism for replacement of lost protein following cell injury and necrosis.
心脏肌钙蛋白T(cTnT)已被认为是一种新的、更具特异性的心肌细胞损伤标志物。本研究的目的是检测犬和人类正常及患病心脏组织中cTnT和肌酸激酶(CK)-MB的分布,并评估血清cTnT在估计犬梗死面积中的应用。
从正常犬(对照组,n = 3)和接受外科冠状动脉闭塞术的犬(n = 6)中获取7天内的系列血清样本。从对照组和实验犬闭塞3周后获取心肌样本。从死于急性心肌梗死的患者(n = 3)尸检中获取患病人类心肌样本。从死于非心脏相关疾病的患者尸检中获取正常心肌样本(n = 3)。将组织切片并匀浆以收获胞质和肌原纤维结合蛋白。检测血清样本和组织匀浆中的cTnT、CK-MB和肌红蛋白(仅针对人类)。检测匀浆样本中的总蛋白,结果以每克总蛋白毫克数报告。
正常人类心脏14个部位的cTnT、CK-MB和肌红蛋白分布相当。肌酸激酶-MB和肌红蛋白超过99%存在于胞质中。心脏肌钙蛋白T 92%与肌原纤维结合,8%存在于胞质中。在对照犬心脏中,右心室的cTnT高于左心室,而CK-MB低于左心室。虽然CK-MB和肌红蛋白超过99%存在于胞质中,但cTnT 98%与肌原纤维结合,2%存在于胞质中。犬心脏梗死面积最初与血清cTnT或CK-MB浓度相关性不佳。然而,当按梗死部位(右冠状动脉;左旋支冠状动脉)对数据进行分类时,相关性显著改善。左、右心室之间cTnT和CK-MB组织浓度的差异可能解释了相关性的变化。犬和人类冠状动脉闭塞导致患病心肌组织中胞质和肌原纤维cTnT减少,CK-MB和肌红蛋白增加。
我们观察到的生化改变表明,细胞损伤后产生能量的蛋白CK-MB和肌红蛋白上调,而结构和调节蛋白cTnT在细胞损伤和坏死后没有丢失蛋白的替代机制。